ARTICLE | Clinical News
Regorafenib regulatory update
May 28, 2012 7:00 AM UTC
Bayer submitted regulatory applications in the EU and U.S. for regorafenib to treat metastatic colorectal cancer (mCRC). Onyx Pharmaceuticals Inc. (NASDAQ:ONXX, South San Francisco, Calif.) has co-pr...